The sponsor is doing this study because they want to learn certain things about the study drug Lenacapavir (LEN), including: • How LEN moves through the body. • How safe and tolerable LEN is when injected into the muscle once yearly.
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
For Researchers
Questions?